First launched in 2022, the Outstanding Paper Award is an award aimed at recognising the high-quality work published in CrystEngComm from the previous year, acknowledging the excellence of the paper as a whole and recognising the contributions of all the authors.
Congratulations to the winners of the 2024 CrystEngComm Outstanding Paper Award, as selected by the Editorial Board, for their work on Integration of a model-driven workflow into an industrial pharmaceutical facility: supporting process development of API crystallisation: Thomas Pickles, Vaclav Svoboda, Ivan Marziano, Cameron J. Brown and Alastair J. Florence
The authors presented a resource efficient yet scalable pharmaceutical crystallisation process development using a model-driven workflow.
Meet the authors of this Outstanding Paper
Thomas Pickles
Thomas joined CMAC in October 2020 where he completed his PhD within the Florence Group with his thesis titled the “Intensification of a workflow for particle engineering and crystallisation process development”. After the completion of his PhD he worked in the pharmaceutical industry for Pfizer R&D UK before returning to CMAC in 2024 as a PDRA working on the core project “Automated model-based design of experiments for crystallisation process development”. More recently, Thomas has moved into a project research scientist role working on the multi-institutional and disciplinary collaborative project “Test Beds for MediForge – Industry 5.0 medicines manufacturing research hub”. The project integrates laboratory equipment for end-to-end synthesis, crystallisation, isolation, drying and drug product development with machine learning and automation. This project aims to reduce material usage and streamline development timelines for use in pharmaceutical manufacturing at the many gram scale.
Vaclav Svoboda
Vaclav Svoboda is a crystallization scientist at Pfizer with a PhD in chemical engineering from the University of Strathclyde. He develops processes for active pharmaceutical ingredients (APIs), collaborates across teams to scale up crystallizations and isolations to pilot and commercial scale. His research interests include continuous crystallization, wet milling, particle engineering, drying and process modelling. Vaclav has worked with both academia and industry to advance crystallization science for drug development.
Ivan Marziano
Despite not having yet fulfilled his childhood dream of acquiring superpowers through an experiment gone south, Ivan has enjoyed a successful 25+ year career as a pharmaceutical chemist. An internationally recognised leader in crystallization, he has contributed to the launch of many new medicines and the introduction of novel technologies, and is now serving as CSIO of Particology, a Kent-based contract research organisation. Ivan is also passionate about DEI, with his endeavours recognised with a 2024 WISE (Women in Science and Engineering) Ally Award. Outside of work, when he is not busy polishing his RSC Fellowship certificate, Ivan is an avid music fan.
Cameron J. Brown
Cameron is a Reader in Digital Pharmaceutical Manufacturing for the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde, Glasgow. Specialising in the development of digital design tools and strategies for pharmaceutical manufacturing. He is a Chemical Engineering graduate of Heriot-Watt University, where he also obtained his PhD in the characterisation of crystallisation processes. He joined Strathclyde University in 2014 and has been through many roles as research associate, research fellow, and Chancellor’s fellow. Currently a member of the Acceleration Consortium and committee member of the British Association of Crystal Growth. His current research is focused on the development and application of modelling approaches for pharmaceutical manufacturing, including GenAI, self-driving labs, hybrid physics/data approaches. Currently principal investigator for PharmaCrystNet and co-investigator on the MediForge: Industry 5.0 Medicines Manufacturing Hub and Digital Design and Manufacturing of Amorphous Pharmaceuticals. Knowledge exchange activities include pre-competitive and one-to-one projects with the leading pharmaceutical companies as well as knowledge transfer partnerships. Currently, Cameron co-ordinates and delivers the Drug Substance Manufacturing module as part of the Advanced Pharmaceuticals Manufacturing MSc course at the University of Strathclyde.
Alastair J. Florence
Alastair Florence is a distinguished professor in pharmaceutical sciences at the University of Strathclyde and is Director of CMAC, providing leadership across the portfolio, engaging with key stakeholders, and driving the centre’s vision to transform the development and manufacture of medicines. Alastair leads a number of major programs across the portfolio including the new flagship EPSRC MediForge Industry 5.0 Manufacturing Hub, Centre for Doctoral Training in Cyber-physical systems (CEDAR) and the £33M UK-RPIF funded CMAC Data Lab partnership. He leads the multidisciplinary, multi-institution academic team driving ambitious manufacturing research, training, translation and facilities programs and working in close collaboration with industry partners to understand challenges and develop effective solutions across CMAC programs. His research interests lie in the science and technology associated with continuous crystallization, physical form control and advanced characterization of pharmaceutical materials and the development of digital technologies to transform the development and manufacture of medicines.
Read the full outstanding article:
Integration of a model-driven workflow into an industrial pharmaceutical facility: supporting process development of API crystallisation
Thomas Pickles, Vaclav Svoboda, Ivan Marziano, Cameron J. Brown and Alastair J. Florence CrystEngComm, 2024, 26, 4678-4689 |
![]() |
Please join us in congratulating this year’s winners!